Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

J E Fisher, M J Rogers, J M Halasy, S P Luckman, D E Hughes, P J Masarachia, G Wesolowski, R G G Russell, G A Rodan, A A Reszka

Research output: Contribution to journalArticlepeer-review

666 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro'. Together they form a unique fingerprint.

Chemical Compounds